Clik here to view.
OliX Pharmaceuticals to Conduct Business Meetings with Potential Partners at...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will participate in one-on-one partnering...
View ArticleClik here to view.
OliX Pharmaceuticals Subsidiary mCureX Announces mRNA Technology...
SUWON, South Korea OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, today announced that the Company’s subsidiary mCureX Therapeutics, Inc. has recently signed a contract for...
View ArticleClik here to view.
BeiGene Announces Acceptance of Supplemental Biologics License Application in...
CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
U.S. Government Guidance Permits DNA Traceability and Isotopic Testing as...
STONY BROOK, N.Y. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, has been increasing its engagement with all stakeholders in anticipation...
View ArticleClik here to view.
Kubota Vision Announced End of Phase 3 Clinical Trial of Emixustat in...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the...
View ArticleClik here to view.
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to...
SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its...
View ArticleClik here to view.
Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced late-breaking data from the Phase 3 SPRING study (NCT04070326) presented at the European Academy of Allergy and...
View ArticleClik here to view.
Sensorion Announces Approval in Australia to Initiate Proof of Concept...
MONTPELLIER, France Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...
View ArticleClik here to view.
OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced the submission of an Investigational New Drug (IND) application to the US...
View ArticleClik here to view.
Proteintech Group Inc. opens new Singapore office
ROSEMONT, Ill. & SINGAPORE Proteintech, the benchmark in antibodies, Nanobodies, and cytokines & growth factors, today announces the opening of its new Singapore office and warehouse at The...
View ArticleClik here to view.
BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
The Sino-American Pharmaceutical Professionals Association-Greater...
PHILADELPHIA The Inaugural @Philly Cell and Gene Therapy Annual Conference (https://atphilly.org/) was held on June 17-18 at the Sheraton Valley Forge Hotel northwest of Philadelphia. Organized by...
View ArticleClik here to view.
PHC株式会社：PHCbi、独自の電気化学式センサー技術を活用した研究用「ライブセル代謝分析装置」のプロトタイプを開発～細胞治療の産業化に向けた課題解決へ...
東京 （ビジネスワイヤ） — ライフサイエンス分野において研究・医療支援機器およびサービスをグローバルに提供するPHC株式会社 バイオメディカ事業部（以下、「PHCbi」）は、7月13日（水）から7月15日（金）まで東京ビッグサイトで開催される「第4回ファーマラボEXPO東京」（主催：RX...
View ArticleClik here to view.
BeiGene Appoints Chan Lee as General Counsel
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology biotechnology company focused on developing and commercializing innovative...
View ArticleClik here to view.
Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event
COLLEGE STATION, Texas Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene...
View ArticleClik here to view.
Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability
PERTH, Australia & HEIDELBERG, Germany Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO based in...
View ArticleClik here to view.
OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s...
View ArticleClik here to view.
GenomOncology和Congenica宣布合作开发新型精准肿瘤学解决方案
英格兰剑桥 (美国商业资讯)–Congenica是一家总部位于英国的数字健康公司，致力于实现基因组数据的快速分析与解读。该公司已选择GenomOncology的精准肿瘤学平台来开发一种新颖的突破性CE-IVD精准肿瘤学解决方案。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20220803005524/zh-CN/...
View ArticleClik here to view.
BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in China...
SHANGHAI BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug...
View ArticleClik here to view.
ゲノムオンコロジーとコンジェニカが新規精密オンコロジーソリューションの共同開発を発表
英ケンブリッジ （ビジネスワイヤ） — ゲノムデータの迅速な解析と解釈を実現する英国のデジタルヘルス企業であるコンジェニカは、画期的な新規CE-IVD精密オンコロジーソリューションの開発にゲノムオンコロジーの精密オンコロジープラットフォームを採用しました。...
View Article